Dr. Peter Mogayzel is a professor of pediatrics at the Johns Hopkins University School of Medicine. His areas of clinical expertise include pediatric pulmonary medicine and the treatment of cystic fibrosis. He has served as the director of the Johns Hopkins Cystic Fibrosis Center since 2002. 

Dr. Mogayzel attended Brown University and received his M.D. and Ph.D. degrees from Boston University and an M.B.A. from Johns Hopkins University. He completed his pediatric residency at the University of Washington, and finished pediatric pulmonary and pediatric critical care fellowships at Johns Hopkins in 1998 before joining the faculty. 

His research interests include the regulatory properties of the CFTR gene, mucociliary clearance and development of new therapeutics for cystic fibrosis.

Dr. Mogayzel is a fellow of American College of Chest Physicians and the American Academy of Pediatrics, and a member of several societies including the American Thoracic Society. 

He has published many journal articles and several book chapters on a variety of topics related to cystic fibrosis. Dr. Mogayzel is an ad hoc reviewer for several journals, including the Journal of Cystic Fibrosis and American Journal of Respiratory and Critical Care Medicine. He serves as chairman of the Clinical Practice Guidelines for Pulmonary Therapies Committee and the Therapeutic Development Network Protocol Review Committee, both of the Cystic Fibrosis Foundation. He is also a past chairman of the Cystic Fibrosis Foundation Center Committee that accredits cystic fibrosis centers in the U.S.

View full profile